Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
S. Korea not to attend Sado mine memorial: foreign ministry
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
PM visits Samsung Biologics, but keeps quiet on availability of Moderna doses
Company embarks on production of coronavirus vaccine for overseas markets as govt seeks to obtain more for Korea
By Kim Byung-wookPublished : Sept. 3, 2021 - 20:03
Prime Minister Kim Boo-kyum visited Samsung Biologics’ headquarters in Incheon on Friday but remained silent on how many doses of the Moderna coronavirus vaccine the company would make available for use in South Korea.
During his visit Kim checked Samsung Biologics’ facility, where hundreds of millions of doses of the Moderna vaccine will be manufactured starting this month. Despite being produced here, the vaccine is destined for overseas markets.
But as Moderna struggles to fulfill vaccine orders, the government is negotiating with the US drugmaker to prioritize Korea.
The prime minister’s visit received nationwide attention, with many asking whether the government had managed to reach a consensus with Moderna, but Kim isn’t giving out any details.
“I express my gratitude for Samsung Biologics’ staff and executives for providing support in many ways amid the pandemic. (Samsung Biologics’) partnership with Moderna will make (Korea) the hub of global vaccine supplies,” Kim said at the event.
Moderna has until Sunday to deliver 4.98 million doses of the vaccine to Korea, which aims to give first shots to at least 70 percent of its population before Chuseok, the Korean equivalent of Thanksgiving.
Earlier last month, delayed shipments of the Moderna vaccine forced Korea to widen the interval between shots to six weeks instead of the recommended four.
During his visit Kim checked Samsung Biologics’ facility, where hundreds of millions of doses of the Moderna vaccine will be manufactured starting this month. Despite being produced here, the vaccine is destined for overseas markets.
But as Moderna struggles to fulfill vaccine orders, the government is negotiating with the US drugmaker to prioritize Korea.
The prime minister’s visit received nationwide attention, with many asking whether the government had managed to reach a consensus with Moderna, but Kim isn’t giving out any details.
“I express my gratitude for Samsung Biologics’ staff and executives for providing support in many ways amid the pandemic. (Samsung Biologics’) partnership with Moderna will make (Korea) the hub of global vaccine supplies,” Kim said at the event.
Moderna has until Sunday to deliver 4.98 million doses of the vaccine to Korea, which aims to give first shots to at least 70 percent of its population before Chuseok, the Korean equivalent of Thanksgiving.
Earlier last month, delayed shipments of the Moderna vaccine forced Korea to widen the interval between shots to six weeks instead of the recommended four.
